| Autor: |
Tryndyak VP; Division of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA., Willett RA; Division of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA., Avigan MI; Office of Pharmacovigilance and Epidemiology, FDA-Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Sanyal AJ; Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA., Beland FA; Division of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA., Rusyn I; Department of Veterinary Integrative Biosciences, Texas A&m University, College Station, Texas, USA., Pogribny IP; Division of Biochemical Toxicology, FDA-National Center for Toxicological Research, Jefferson, Arkansas, USA. |
| Abstrakt: |
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease, and patient susceptibility to its onset and progression is influenced by several factors. In this study, we investigated whether altered hepatic DNA methylation in liver tissue correlates with the degree of severity of NAFLD-like liver injury induced by a high-fat and high-sucrose (HF/HS) diet in Collaborative Cross (CC) mice. Using genome-wide targeted bisulphite DNA methylation next-generation sequencing, we found that mice with different non-alcoholic fatty liver (NAFL) phenotypes could be distinguished by changes in hepatic DNA methylation profiles. Specifically, NAFL-prone male CC042 mice exhibited more prominent DNA methylation changes compared with male CC011 mice and female CC011 and CC042 mice that developed only a mild NAFL phenotype. Moreover, these mouse strains demonstrated different patterns of DNA methylation. While the HF/HS diet induced both DNA hypomethylation and DNA hypermethylation changes in all the mouse strains, the NAFL-prone male CC042 mice demonstrated a global predominance of DNA hypermethylation, whereas a more pronounced DNA hypomethylation pattern developed in the mild-NAFL phenotypic mice. In a targeted analysis of selected genes that contain differentially methylated regions (DMRs), we identified NAFL phenotype-associated differences in DNA methylation and gene expression of the Apoa4, Gls2 , and Apom genes in severe NAFL-prone mice but not in mice with mild NAFL phenotypes. These changes in the expression of Apoa4 and Gls2 coincided with similar findings in a human in vitro cell model of diet-induced steatosis and in patients with NAFL. These results suggest that changes in the expression and DNA methylation status of these three genes may serve as a set of predictive markers for the development of NAFLD. |
